10 medical affairs experts

Head of medical affairs is a current title for five of these medical affairs experts, at Ardelyx, Vertex Pharmaceuticals, Bristol Meyers Squibb, Monopar Therapeutics and argenx, and a past one for the other five, at Seres Therapeutics, PharmaEssentia, Valneva, Nobelpharma America and Eli Lilly and Company. They suit a drug company building medical affairs ahead of a launch, sizing a medical science liaison team or planning evidence after approval.

10 professionals10 companiesData retrieved October 3, 2026

Professionals to explore

  1. Elizabeth A. Pappadopulos

    LinkedIn

    Experience: Former VP, Head of Medical Affairs - Psychiatry · Bristol Meyers Squibb

    $1,010 per 30-minute call

    Elizabeth A. Pappadopulos became VP, Head of Medical Affairs - Psychiatry at Bristol Meyers Squibb in May 2026, after CNS Therapeutic Area Lead - Psychiatry at AbbVie (2024–2026). Elizabeth was Executive Director Medical Affairs - Neurology at Eisai US (2021–2024), and at Pfizer was Global Lead Medical Affairs - CNS (2014–2021) and Director, Global Rare Disease Specialist (2012–2014). The pick for medical affairs questions in psychiatry, neurology and rare disease.

    Is this you? Claim your profile and get paid for calls.

  2. Ellen Shannon PhD, RN, MSL-BC

    LinkedIn

    Experience: Former US Head of Medical Affairs · Valneva

    $673 per 30-minute call

    Ellen Shannon PhD, RN, MSL-BC was US Head of Medical Affairs at Valneva (2019–2024) and has been Senior Director Medical Affairs at Vaxcyte since April 2026, after Field Medical Director at Pfizer (2024–2026). At Sanofi, Ellen was Regional Director- US Medical Science Liaison Team (2014–2019) and Medical Science Liaison (2006–2014). In their own words, Ellen builds medical affairs functions from the ground up and has done it more than once, which makes Ellen the call for a first build.

    Is this you? Claim your profile and get paid for calls.

  3. Eric Beresford, PharmD, BCMAS

    LinkedIn

    Experience: Former VP, Head of Medical Affairs · Nobelpharma America, LLC

    $673 per 30-minute call

    Eric Beresford, PharmD, BCMAS was VP, Head of Medical Affairs at Nobelpharma America, LLC (2020–2024), with a successful product launch of HYFTOR (sirolimus topical gel) 0.2% and work with the advocacy group TSC Alliance. Eric was also Director Medical Affairs - Rare Diseases at Liminal BioSciences (2017–2020), Sr Global Medical Affairs Leader - Immunology & Inflammation at AstraZeneca (2014–2016) and Medical Affairs Director - Antibacterial Agts at Allergan (2011–2014). Fits rare disease launch questions, including work with patient advocacy groups.

    Is this you? Claim your profile and get paid for calls.

  4. Jeffrey Kent, MD

    LinkedIn

    Experience: Former Senior Vice President, Head of Medical Affairs & Outcomes Research · Horizon

    $1,683 per 30-minute call

    Since August 2026, Jeffrey Kent, MD has been Executive Vice President, Head of Medical Affairs at Monopar Therapeutics Inc., after Chief Medical Officer at Sling Therapeutics (2023–2026). At Horizon, Jeffrey was Executive Vice President, Medical Affairs and Outcomes Research (2019–2023) and Senior Vice President, Head of Medical Affairs & Outcomes Research (2012–2019), and was Executive Medical Director at Astellas Pharma (2011–2012). The Horizon titles make Jeffrey a fit for questions on pairing medical affairs with outcomes research.

    Is this you? Claim your profile and get paid for calls.

  5. Jessica Nora

    LinkedIn

    Experience: SVP, Head of Medical Affairs · Vertex Pharmaceuticals

    $2,019 per 30-minute call

    Jessica Nora has been SVP, Head of Medical Affairs at Vertex Pharmaceuticals since August 2024, after Head of Business Transformation and Planning at AstraZeneca (2023–2024). Jessica was President of JN Strategic Consulting (2022–2023) and, at BioMarin Pharmaceutical Inc., Vice President, Head of Product and Portfolio Strategy (2020–2022) and Executive Director, Core Team Lead Hemophilia (2020–2021), and describes developing and launching products. A fit for questions on organizing medical affairs around a launch and portfolio.

    Is this you? Claim your profile and get paid for calls.

  6. Joshua Bryson

    LinkedIn

    Experience: Head of US Medical Affairs and Evidence Generation · argenx

    $1,010 per 30-minute call

    Joshua Bryson has been Head of US Medical Affairs and Evidence Generation at argenx since December 2024 and was Vice President, Head of US Medical Immunology at Bristol Myers Squibb (2023–2025). Joshua's other Bristol Myers Squibb titles were Executive Director, Sotyktu (deucravacitinib) US Medical Lead (2021–2023), Director, US Medical Lead Deucravacitnib (2019–2021) and Associate Medical Director, Rheumatology and Immunology (2017–2019). Having been US medical lead for one product, Joshua fits questions on adoption of new immunology medicines and evidence generation.

    Is this you? Claim your profile and get paid for calls.

  7. Murali Gopal, M.D.

    LinkedIn

    Experience: Senior Vice President, Head of Medical Affairs · Ardelyx, Inc.

    $1,211 per 30-minute call

    Murali Gopal, M.D. has been Senior Vice President, Head of Medical Affairs at Ardelyx, Inc. since August 2025, setting all Medical Affairs strategies in support of Development and Commercial programs. Murali was also Vice President, Head - Medical Affairs at Phathom Pharmaceuticals (2022–2025), Chief Medical Officer at Indivior (2021) and Vice President Global Medical Department at Mallinckrodt Pharmaceuticals (2020–2021). Having headed medical affairs at two companies, Murali fits questions on aligning medical strategy with commercial plans.

    Is this you? Claim your profile and get paid for calls.

  8. Paul D. Walden

    LinkedIn

    Experience: Former Head of Medical Affairs · PharmaEssentia

    $673 per 30-minute call

    Paul D. Walden was Head of Medical Affairs at PharmaEssentia (2024–2025), directing teams for scientific communications, medical information, health economic outcomes research (HEOR), real-world evidence generation and publications. Paul was also VP Medical Affairs at Celltrion Inc (2023–2024), VP, Medical Affairs (2022–2023) and Executive Director, Medical Affairs (2020–2022) at Coherus Oncology, and Executive Director, Medical Affairs at Heron Therapeutics, Inc. (2018–2020). Suited to questions on which sub-teams a medical affairs function needs.

    Is this you? Claim your profile and get paid for calls.

  9. Robert Stevens, PharmD

    LinkedIn

    Experience: Former Vice President and Head, Medical Affairs · Seres Therapeutics

    $808 per 30-minute call

    At Seres Therapeutics, Robert Stevens, PharmD was Vice President and Head, Medical Affairs (2021–2025), Executive Director, Medical Affairs (2020–2021) and Senior Medical Director, Medical Affairs (2016–2017). Robert also held Senior Director, Medical Affairs titles at Nabriva Therapeutics plc (2019–2020) and Achaogen (2017–2018). Holding senior medical director, executive director and head titles at Seres suits questions on how medical affairs leadership roles change over time at one company.

    Is this you? Claim your profile and get paid for calls.

  10. Sarah Rybowski

    LinkedIn

    Experience: Former Head of Global US Medical Affairs Oncology (Breast franchise) · Eli Lilly and Company

    $1,346 per 30-minute call

    Sarah Rybowski was Head of Global US Medical Affairs Oncology (Breast franchise) at Eli Lilly and Company (2021–2024) and has been VP Global Medical Strategy, Scientific Communications and Publications at Insmed Incorporated since March 2024. Sarah, a medical doctor, was also US Medical Lead, Global Medical Affairs Oncology at Lilly (2019–2021) and Global Real World Evidence Strategy Lead Oncology at Bayer (2016–2019), and describes product launches for multi-billion dollar product lines. A fit for launch strategy and publication planning in oncology.

    Is this you? Claim your profile and get paid for calls.

Choose the right perspective

Ellen Shannon has built medical affairs functions from the ground up more than once and held medical science liaison roles at Sanofi, so fits a first build; Eric Beresford, Sarah Rybowski and Jessica Nora cite product launches. For evidence generation and outcomes research, try Joshua Bryson, Jeffrey Kent or Paul D. Walden, and go to Elizabeth A. Pappadopulos for psychiatry and CNS.

Questions to take into the conversation

  1. 01How large should a medical science liaison team be at a first product launch, and how should it be split across territories?
  2. 02Which medical affairs hires should come a year or more before approval, and which can wait until after launch?
  3. 03How should a medical affairs team plan real-world evidence and publications once a drug is on the market?

About this directory

This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.

Other perspectives in Pharmaceuticals